OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Fresenius Medical Care AG/  US3580291066  /

NYSE
2024-04-15  10:10:00 PM Chg. +0.38 Volume Bid2:00:00 AM Ask2:00:00 AM Market Capitalization Dividend Y. P/E Ratio
18.77USD +2.07% 516,069
Turnover: 8.04 mill.		 17.86Bid Size: 100 19.11Ask Size: 100 12.29 bill.USD - -
GlobeNewswire 03-14 CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
GlobeNewswire 02-23 Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire 02-04 China Medical System (00867） Obtained Exclusive License of a First-line Phosphate-lowering Drug Velp...
GlobeNewswire 01-04 Sigyn Therapeutics Releases Letter to Shareholders
GlobeNewswire 2023-11-09 CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
GlobeNewswire 2023-09-19 ONWARD® Reports 2023 Half Year Results and Business Update
GlobeNewswire 2023-09-04 CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire 2023-08-31 CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
GlobeNewswire 2023-08-24 CIO Leadership: The Steps Needed to Build a High-Performance Culture Will Power the Discussion at th...
TeleTrader 2022-12-12 Europe closes lower as investors brace for CPI data
TeleTrader 2022-12-06 European markets close with losses after data
TeleTrader 2022-11-01 Europe markets higher at open ahead of Fed decision
TeleTrader 2022-10-31 Europe closes mostly higher, inflation hits new record
GlobeNewswire 2022-03-29 Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update
TeleTrader 2022-03-25 Europe closes mostly higher after US, EU energy deal
GlobeNewswire 2022-03-14 Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
GlobeNewswire 2022-03-01 Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 2022-02-28 Humacyte Announces Publication of Positive Long-Term Follow-Up Data from Phase 2 Trial of HAV™ for H...
GlobeNewswire 2022-02-25 Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...
GlobeNewswire 2022-02-24 OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results
GlobeNewswire 2022-02-24 Dentsply Sirona Announces Appointment of Dr. Dorothea Wenzel as New Board Member
GlobeNewswire 2022-02-03 RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP
GlobeNewswire 2022-01-31 Humacyte Announces Clinical Case Series Demonstrating Potential of Human Acellular Vessel™ (HAV™) to...
GlobeNewswire 2022-01-28 Humacyte Announces Preclinical Results of Small-Diameter Human Acellular Vessel™ (HAV™) in Coronary ...
TeleTrader 2022-01-25 Europe shrugs off global turmoil, ends higher